Radiosyn - About the company
Radiosyn is an unfunded company. It operates as a Manufacturer of miniaturized automated platforms for synthesizing radiopharmaceutical chemical compounds. Radiosyn has not raised any funding yet. The company has 51 active competitors, including 10 funded and 6 that have exited. Its top competitors include companies like microLIQUID, Noul and SpacePharma.
Company Details
Manufacturer of miniaturized automated platforms for synthesizing radiopharmaceutical chemical compounds. These systems utilize disposable microfluidic chips to perform end-to-end chemical and radiochemical reactions. The technology standardizes the production of radioimmunoconjugates and radiopharmaceuticals for diagnostic and therapeutic applications. By automating the synthesis process, the equipment enables the production of these substances in research and clinical environments without requiring extensive manual radiochemistry expertise.
Key Metrics
Stage
Unfunded
Ranked
35th among 51 active competitors
Employee Count
7 as on Sep 30, 2026
Similar Companies
Sign up to download Radiosyn's company profile
Radiosyn's funding and investors
Radiosyn has not raised any funding rounds yet.
Radiosyn's founders and board of directors
Founder? Claim ProfileRadiosyn's employee count trend
Radiosyn has 7 employees as of Sep 26. Here is Radiosyn's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Radiosyn's Competitors and alternates
Top competitors of Radiosyn include microLIQUID, Noul and SpacePharma. Here is the list of Top 10 competitors of Radiosyn, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | microLIQUID 2008, Bilbao (Spain), Acquired | Specializes in microfluidics | - | 48/100 | |
2nd | Noul 2015, Yongin si (South Korea), Public | AI-based digital microscope platform for blood analysis | - | 45/100 | |
3rd | SpacePharma 2012, Herzliya (Israel), Series A | Provider of microgravity research solutions for researchers, institutes, and commercial companies | $5M | 40/100 | |
4th | Provider of microfluidic technology and solutions for life sciences industries | - | 40/100 | ||
5th | Developer of a lab on chip microfluidic platform for sequencing and molecular diagnostics using AI | $200M | 39/100 | ||
6th | Micronit 1999, Enschede (Netherlands), Funding Raised | Microfluidic design and manufacturing | - | 36/100 | |
7th | Fluxus 2016, Sunnyvale (United States), Funding Raised | Provider of ultrasensitive bioanalysis systems and solutions | - | 35/100 | |
8th | Accel Diagnostics 2012, Pittsburgh (United States), Public | Rapid, reliable, and affordable diagnostic lab testing services in Houston | $950K | 33/100 | |
9th | Finnadvance 2018, Oulu (Finland), Seed | Developer of microfluidics and microtechnology solutions for drug development | $1.9M | 33/100 | |
10th | Avery Digital 2020, Iceland, Funding Raised | Developer of CMOS chips to help in research and development for bioengineers | - | 33/100 | |
35th | ![]() Radiosyn Unfunded | Manufacturer of miniaturized automated platforms for synthesizing radiopharmaceutical chemical compounds | - | - | 19/100 |
Looking for more details on Radiosyn's competitors? Click here to see the top ones
Radiosyn's Investments and acquisitions
Radiosyn has made no investments or acquisitions yet.
Reports related to Radiosyn
Here is the latest report on Radiosyn's sector:
Are you a Founder ?
FAQs about Radiosyn
Explore our recently published companies
- NaturEco - Jabalpur based, 2023 founded, Unfunded company
- Bpacks - Belgrade based, 2022 founded, Seed company
- Insignia Technologies - Motherwell based, 2012 founded, Series A company
- Isochronic - Pully based, 2019 founded, Seed company
- Nanocaresa - South Africa based, Unfunded company
- Olivello - Italy based, Unfunded company
